stoxline Quote Chart Rank Option Currency Glossary
  
Silk Road Medical, Inc (SILK)
17.75  0.34 (1.95%)    04-23 09:45
Open: 17.39
High: 17.77
Volume: 19,731
  
Pre. Close: 17.41
Low: 17.345
Market Cap: 695(M)
Technical analysis
2024-04-23 9:19:52 AM
Short term     
Mid term     
Targets 6-month :  21.16 1-year :  22.9
Resists First :  18.12 Second :  19.61
Pivot price 17.77
Supports First :  15.71 Second :  13.07
MAs MA(5) :  17.46 MA(20) :  17.93
MA(100) :  14.89 MA(250) :  19.17
MACD MACD :  0 Signal :  0.2
%K %D K(14,3) :  27.6 D(3) :  29
RSI RSI(14): 47.9
52-week High :  45.4 Low :  6.07
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ SILK ] has closed above bottom band by 32.4%. Bollinger Bands are 36.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 17.69 - 17.8 17.8 - 17.91
Low: 16.56 - 16.7 16.7 - 16.83
Close: 17.18 - 17.41 17.41 - 17.63
Company Description

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

Headline News

Tue, 23 Apr 2024
Silk Road Medical (SILK) to Release Earnings on Tuesday - MarketBeat

Tue, 09 Apr 2024
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024 - GlobeNewswire

Mon, 08 Apr 2024
Silk Road Medical's (SILK) New Launch to Aid Its TCAR Portfolio - Yahoo Finance

Tue, 02 Apr 2024
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS - GlobeNewswire

Thu, 07 Mar 2024
Silk Road Medical's (SILK) New Stent Expands Its TCAR Portfolio - Yahoo Finance

Tue, 05 Mar 2024
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 39 (M)
Shares Float 38 (M)
Held by Insiders 5.9 (%)
Held by Institutions 106.9 (%)
Shares Short 4,090 (K)
Shares Short P.Month 4,320 (K)
Stock Financials
EPS -1.45
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.85
Profit Margin -31.5 %
Operating Margin -30.4 %
Return on Assets (ttm) -13.9 %
Return on Equity (ttm) -35.4 %
Qtrly Rev. Growth 18 %
Gross Profit (p.s.) 0
Sales Per Share 4.52
EBITDA (p.s.) -1.45
Qtrly Earnings Growth 0 %
Operating Cash Flow -32 (M)
Levered Free Cash Flow -12 (M)
Stock Valuations
PE Ratio -12.1
PEG Ratio -0.8
Price to Book value 4.51
Price to Sales 3.84
Price to Cash Flow -21.31
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android